MIST Milestone Pharmaceuticals Inc.

NASDAQ
$0.37

Milestone Pharmaceuticals Inc. (MIST) Earnings News

Earnings press releases, previews and reviews for Milestone Pharmaceuticals Inc. (MIST), newest first. Our most recent is review: Milestone Pharmaceuticals Beats on a One-Time License Payment, but a 30% Cost Cut Shows the CARDAMYST Launch Is Running Below Plan.